Utah Retirement Systems Iovance Biotherapeutics, Inc. Transaction History

Utah Retirement Systems

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $117,575 - $238,104	-7,200 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $2,867 - $5,259	100 Added 1.41%	7,200 $228,000
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $199,084 - $356,846	7,100 New	7,100 $329,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

Stay updated on Utah Retirement Systems with notifications on news.